MedPath

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma

Phase 2
Completed
Conditions
Aspergillosis
Lung Diseases, Fungal
First Posted Date
2001-08-31
Last Posted Date
2010-08-27
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
96
Registration Number
NCT00005668
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Mary Ellen Bradley, Birmingham, Alabama, United States

A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome

Not Applicable
Completed
Conditions
Hantavirus Pulmonary Syndrome
First Posted Date
2001-08-31
Last Posted Date
2010-08-27
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
130
Registration Number
NCT00001123
Locations
๐Ÿ‡บ๐Ÿ‡ธ

NIAID/DMID/CASG Central Unit, Birmingham, Alabama, United States

A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.

Phase 3
Completed
Conditions
Cytomegalovirus Infections
First Posted Date
2001-08-31
Last Posted Date
2010-08-27
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
130
Registration Number
NCT00001100
Locations
๐Ÿ‡บ๐Ÿ‡ธ

NIAID/DMID/CASG Central Unit, Birmingham, Alabama, United States

Study and Treatment of Post Lyme Disease (STOP-LD)

Phase 3
Completed
Conditions
Lyme Disease
First Posted Date
2001-08-31
Last Posted Date
2010-08-27
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
55
Registration Number
NCT00000937
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Lauren Krupp, Stony Brook, New York, United States

Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants

Phase 4
Completed
Conditions
Candidiasis
First Posted Date
2001-08-31
Last Posted Date
2010-08-27
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
500
Registration Number
NCT00001107
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Mary Ellen Bradley, Birmingham, Alabama, United States

Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines

Phase 1
Completed
Conditions
Bacterial Infections
Group B Streptococcus
First Posted Date
2001-08-31
Last Posted Date
2010-08-27
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
65
Registration Number
NCT00008853
Locations
๐Ÿ‡บ๐Ÿ‡ธ

AIDS Ctr, New York, New York, United States

A Study of BufferGel in Women

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2007-01-09
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
40
Registration Number
NCT00000927
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Mem Hosp of Rhode Island, Pawtucket, Rhode Island, United States

Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.

Phase 2
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2011-03-14
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
320
Registration Number
NCT00000678
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Graduate Hosp, Philadelphia, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

Univ of Miami School of Medicine, Miami, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Davies Med Ctr, San Francisco, California, United States

and more 7 locations

Half-Dose Flu Vaccine Study in Healthy Adults

Phase 2
Completed
Conditions
Influenza
First Posted Date
2001-08-31
Last Posted Date
2010-08-27
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
840
Registration Number
NCT00006146
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UCLA Center for Vaccine Research, Torrance, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Baylor College of Medicine, Houston, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Center for Vaccine Development, St Louis, Missouri, United States

and more 3 locations

Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women

Completed
Conditions
HIV Infections
Pregnancy
First Posted Date
2001-08-31
Last Posted Date
2006-08-07
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
160
Registration Number
NCT00017797
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The CORE Ctr, Chicago, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

Univ of Pittsburgh, Pittsburgh, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

Univ of Miami (Pediatric), Miami, Florida, United States

and more 37 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath